Prevalence of neurological complications in Japanese patients with AIDS after the introduction of HAART

Clinical Neurology

Volumn 47, Issue 8, 2007, Pages 491-496

  Yoritaka, Asako ^a   Ohta, Keiko ^a   Kishida, Shuji ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Acquired immunodeficiency syndrome; Central nervous system; Epidemiology; Highly active antiretroviral therapy; Human immunodeficiency virus

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAIN DISEASE; BRAIN LYMPHOMA; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENCEPHALITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAPANESE; MAJOR CLINICAL STUDY; NEUROLOGICAL COMPLICATION; PROMYELOCYTIC LEUKEMIA; QUESTIONNAIRE; SPINAL CORD DISEASE; SURVIVAL; VIREMIA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS ARTERITIS, CENTRAL NERVOUS SYSTEM; AIDS-ASSOCIATED NEPHROPATHY; AIDS-RELATED COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; JAPAN; PREVALENCE; QUESTIONNAIRES;

EID: 34548857614     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nakagawa M, Maruyama Y, Sugita H, et al: Nationwide survey of neurological manifestations of acquired immunodeficiency syndrome in Japan. Intern Med 1997; 36: 175-178
2. Ministry of Health, Labour and Welfare office: 2004 Generation trends of AIDS: outline. Japan (in Japanese)
3. Ruxrungtham K, Brown T, Phnuphak P: HIV/AIDS in Asia. Lancet 2004; 364: 69-82
4. World Health Organization UNAIDS/WHO -2003: AIDS epidemic update: December 2003
5. Sacktor N: The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neuro Virol 2002; 8 (suppl 2): 115-121
6. d'Arminio Monforte A, Cinque P, Mocroft A, et al: Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 2004; 55: 320-328
7. Dore GJ, Correll PK, Li Y, et al: Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999; 13: 1249-1253
8. Anthony IC, Ramage SN, Carnie FW, et al: Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropath Exp Neurol 2005; 64: 529-536
9. Sacktor N, Lyles RH, Skolasky R, et al: HIV-associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990-1998. Neurology 2001; 56: 257-260
10. Oka S, Yasuoka A: Current status of HIV infection in the AIDS Clinical Center (ACC). Intern Med 2002; 41: 58-59
11. Hung C-C, Hsiao C-F, Chen M-Y, et al: Improved survival of persons with human immunodefiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan. Jpn J Infect Dis 2006; 59: 222-228
12. Palella FJ Jr, Delaney KM, Moorman AC, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Eng J Med 1998; 338: 853-860
13. Hoshiba T, Asamoto A, Yabuki Y: Decreasing seropositivity of cytomegalovirus of pregnant women in Japan. Nihonrinsyo 1998; 56: 193-196 (in Japanese)
14. Jellinger KA, Setinek U, Drlicek M, et al: Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 2000; 100: 213-220
15. Ammassari A, Cingolani A, Pezzotti P, et al: AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 2000; 55: 1194-1200
16. Dore GJ, McDonald A, Li Y, et al: Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003; 17: 1539-1545
17. Brew BJ: Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004; 18 (Suppl 1): S75-S78
18. McArthur JC: HIV dementia: an evolving disease. J Neuroimmunol 2004; 157: 3-10
19. Tozzi V, Balestra P, Lorenzini P, et al: Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J NeuroVirol 2005; 11: 265-273
20. Langford TD, Letendre SL, Marcotte TD, et al: Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 2002; 16: 1019-1029
21. Carr A, Samaras K, Thorisdottir A, et al: Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999; 353: 2093-2099